Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma, Synovial × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Leiomyosarcoma 1

Interventions

Ifosfamide 6 Doxorubicin 6 Radiotherapy 4 Filgrastim 2 Etoposide 2 trofosfamide 1 pegfilgrastim 1 indolepropanol phosphate 1 fludarabine 1 anlotinib 1 Watchful Waiting 1 Tablets 1 Rosuvastatin Calcium 1 Radiotherapy, Conformal 1 Observation 1 Midazolam 1 Idarubicin 1 Digoxin 1 Diathermy 1 Dacarbazine 1 Cyclophosphamide 1 Combined Modality Therapy 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03016819 2026-02-25

APROMISS

Advenchen Laboratories, LLC

Phase 3 Recruiting

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡